Patents Assigned to Sigma-Aldrich Company Limited
  • Kinase inhibitor polymorphs
    Patent number: 9403820
    Abstract: Polymorphs of chemical compounds that modulate kinase activity, including PI3K activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3K activity, are described herein.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: August 2, 2016
    Assignees: Intellikine LLC, Sigma-Aldrich Company Limited
    Inventors: Pingda Ren, Michael Martin, Christopher Peter Worrall, Susanna del Rio Gancedo